Coronary Drug Project Mortality Surveillance

• Status: Completed
• Trial end date: 1985-03-01
• Target enrollment: 0
• Participant gender: Male

Summary

To determine whether there were any long term sequelae of the drugs used in the Coronary Drug Project (estrogens, dextrothyroxine, nicotinic acid, clofibrate).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Clofibrate; Estrogens; Niacin

Criteria

No eligibility criteria